IBOK
TAK icon

Independence Bank of Kentucky’s Takeda Pharmaceutical TAK Stock Holding History

Independence Bank of Kentucky’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-201
Closed -$3.13K – 716
2025
Q4 		$3.13K Buy
+201
New +$2.87K ﹤0.01% 613
2019
Q3 		– Sell
-100
Closed -$2K – 364
2019
Q2 		$2K Hold
100
– – ﹤0.01% 306
2019
Q1 		$2K Buy
+100
New +$2.01K ﹤0.01% 311

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Independence Bank of Kentucky's TAK Position: Q1 2026 in Review

Independence Bank of Kentucky sold out of Takeda Pharmaceutical (TAK) in Q1 2026, closing a stake of 201 shares — an estimated $3.13K sold.

Independence Bank of Kentucky first reported a position in TAK in Q1 2019 and held it in 3 quarters. The position peaked at $3.13K in Q4 2025. 360 funds tracked by Wall St. Rank hold TAK as of Q1 2026.

  • Independence Bank of Kentucky reported no remaining Takeda Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Independence Bank of Kentucky sold 201 Takeda Pharmaceutical shares in Q1 2026, an estimated $3.13K.
  • Independence Bank of Kentucky first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 3 quarters.
  • Independence Bank of Kentucky's Takeda Pharmaceutical position peaked at $3.13K in Q4 2025.
  • 360 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2026.

Based on Independence Bank of Kentucky's 13F filing for Q1 2026, filed 30 Apr 2026.